Immune-mediated ataxias: Guide to clinicians

Area of Science:

• Neurology
• Immunology
• Pathology

Background:

• Immune-mediated cerebellar ataxias are a group of neurological disorders affecting cerebellar function.
• First described in the 1980s, understanding has significantly evolved.
• The cerebellum's susceptibility may be linked to increased brain-blood barrier permeability.

Purpose of the Study:

• To provide a comprehensive review of prevalent immune-mediated cerebellar ataxias.
• To highlight key clinical indicators for diagnosis.
• To discuss underlying pathogenesis and current therapeutic strategies.

Main Methods:

• Literature review of established and emerging research on immune-mediated cerebellar ataxias.
• Synthesis of clinical findings, etiological factors, and treatment outcomes.
• Analysis of the role of autoimmune processes and brain-blood barrier integrity.

Main Results:

• Identified key conditions: postinfectious cerebellar ataxia, gluten ataxia, paraneoplastic cerebellar degeneration, opsoclonus-myoclonus-ataxia syndrome, and primary autoimmune cerebellar ataxia.
• Detailed clinical presentations and diagnostic markers for each subtype.
• Summarized current treatment modalities, including immunotherapy and symptomatic management.

Conclusions:

• Immune-mediated cerebellar ataxias represent a diverse group of neurological disorders.
• Accurate diagnosis relies on recognizing specific clinical indicators and understanding pathogenesis.
• Effective management involves tailored treatment approaches based on the underlying autoimmune mechanism.